Clinical trial
A Safety/Efficacy Trial of Zonisamide for Essential Tremor
NCT00223743 · VA Greater Los Angeles Healthcare System, U.S. Fed · Completed
Key facts
| NCT number | NCT00223743 |
|---|---|
| Title | A Safety/Efficacy Trial of Zonisamide for Essential Tremor |
| Official title | Novel Therapies for Essential Tremor - Zonisamide Pilot Study |
| Lead sponsor | VA Greater Los Angeles Healthcare System, U.S. Fed |
| Collaborators | Ralph M. Parsons Foundation |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Essential Tremor |
| Intervention type | Drug |
| Interventions | Zonisamide |
| Enrollment | 25 |
| Start date | Nov 1, 2004 |
| Primary completion | Sep 1, 2008 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 22, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: